As the world continues to navigate through the complexities of the COVID-19 pandemic, a new variant of coronavirus infection emerges every following year, drawing attention from health authorities and the public alike. A new variant called JN.1, a descendant of the BA.2.86, also known as the ‘Pirola’ strain, belonging to the Omicron lineage, is sweeping across Asia and is already present in India.
With almost 250 COVID-19 cases in states like Kerala, Maharashtra, Tamil Nadu and even Gurgaon, it’s important to stay informed about the latest developments. Though the current figures are low, continued monitoring, vaccination and hygiene practices are key to preventing another wave.
This blog aims to provide comprehensive information about JN.1, its characteristics, transmission, symptoms, detection methods, vaccine efficacy, and preventive measures. Please note that this blog is for reference purposes only, and it is always advised to consult the doctor for accurate analysis and ensure effective treatment.
What is JN.1: A New COVID-19 Variant on the Rise
The JN.1 variant has been classified by the World Health Organisation (WHO) as a ‘variant of interest’ due to its rapid spread and potential implications for public health. While it is related to the Omicron lineage, JN.1 carries mutations that may affect its transmissibility and immune evasion capabilities.
JN.1 is a descendant of the BA.2.86 (Pirola) lineage, itself a subvariant of the Omicron strain of SARS-CoV-2. The JN.1 variant is characterised by specific mutations, particularly in the spike protein, which may enhance its ability to evade immune responses. While it retains many of the immune evasion features of its parent, JN.1 has acquired additional mutations that allow it to spread more efficiently compared to earlier Omicron sub variants.
How is JN.1 Different from Earlier COVID Strains?
JN.1, being a subvariant of the Omicron strain, has been the dominant variant that carries specific mutations in the spike protein, which may enhance its ability to spread more quickly. Compared to earlier strains, JN.1 may partially escape immunity from previous infections or vaccinations. This characteristic underscores the importance of continued vigilance and adherence to preventive measures.
How Does JN.1 Spread and How Contagious Is It?
JN.1 spreads primarily through respiratory droplets when an infected person coughs, sneezes, or talks. It can also spread by touching surfaces contaminated with the virus and then touching the face. Early reports indicate that JN.1 might spread faster than previous variants because of its distinct mutation, which could lead to a higher rate of infection in a shorter period. However, the severity of cases linked to JN.1 appears to be relatively low, with most infections remaining mild.
Since this variant may spread more easily than previous strains, it may potentially lead to localised outbreaks. Therefore, doctors emphasise the importance of wearing masks in crowded or enclosed spaces, practising good hand hygiene, and maintaining physical distancing to reduce the risk of transmission.
What are the Symptoms of JN.1 COVID Infections?
The symptoms associated with JN.1 infections are similar to those of earlier Omicron sub variants and are generally mild to moderate. While most individuals recover at home without the need for hospitalisation, some older adults and those with underlying health conditions may experience more severe symptoms and should seek medical attention promptly. Common JN.1 symptoms include:
An elevated body temperature, often above 100.4°F (38°C), is usually accompanied by chills and sweating. It signals the body fighting the infection and may last for several days.
A dry or productive cough that can irritate the throat and chest, worsening over time. It helps expel mucus but may cause discomfort.
Clear nasal discharge and congestion, often accompanied by sneezing. It can lead to irritation in the nasal passages and difficulty breathing.
Pain or irritation in the throat, often dry or scratchy. It may make swallowing uncomfortable and last for several days.
Head pain that ranges from mild to severe, often aggravated by fever and fatigue. It may last throughout the infection.
A feeling of constant tiredness or weakness, making even simple tasks feel exhausting. Rest may not fully relieve the fatigue.
Widespread aches, especially in the back, arms, legs, and joints, are often worsened by fever and chills.
Difficulty breathing, especially for those with pre-existing respiratory conditions. It can range from mild to severe and may indicate complications.
Symptoms like nausea, vomiting, or diarrhoea can lead to dehydration and discomfort. These are less common but still significant.
How is JN.1 Detected Through Testing?
Reverse transcription polymerase chain reaction (RT-PCR) tests remain the gold standard for detecting COVID-19 infections, including those caused by the JN.1 variant. These tests detect viral RNA and are highly sensitive, making them effective for diagnosing infections even in asymptomatic individuals.
Rapid Antigen Tests (RATs)
Rapid antigen tests detect specific proteins on the surface of the virus. While they provide results quickly, their sensitivity may be lower than that of RT-PCR tests, especially in individuals with low viral loads. A negative result from an RAT should be confirmed with an RT-PCR test if symptoms persist or exposure is suspected.
Multiplex PCR tests can simultaneously detect multiple respiratory pathogens, including various COVID-19 variants. These tests can differentiate between different strains, aiding in surveillance and epidemiological studies.
What are the Treatment Options for JN.1 COVID?
Treatment options for JN.1 COVID aim to manage symptoms and ensure adequate rest, while severe cases receive the medical interventions necessary to prevent complications and improve survival rates. If symptoms worsen or respiratory difficulties occur, seeking immediate medical attention is critical. Here are some common treatment options recommended by the doctor:
Treatment for Mild Cases
Rest is essential to allow the body to recover from the infection. Adequate sleep helps strengthen the immune system, speeding up the recovery process.
Fluids are important to stay hydrated, especially when fever, cough, or other symptoms cause fluid loss. Drinking plenty of water, herbal teas, and electrolyte-rich drinks can help maintain hydration and reduce symptoms like dry mouth and throat.
Fever-reducing medications such as paracetamol (acetaminophen) can be used to lower fever and alleviate body aches.
Pain relievers can help reduce headaches, muscle pain, and sore throats, ensuring greater comfort during recovery. However, it's important to follow dosage guidelines and consult a healthcare provider if symptoms persist.
Steam Inhalation and Gargles
Steam inhalation can relieve nasal congestion and soothe the airways. Inhaling warm, moist air can help clear the sinuses and reduce coughing.
Gargling with saltwater can help soothe a sore throat and reduce throat inflammation. It may also help clear mucus from the throat and provide temporary relief.
Self-monitoring of symptoms is crucial. People with mild symptoms should regularly check their temperature, oxygen levels (if available), and overall condition. If there’s any significant worsening of symptoms, medical attention should be sought promptly.
Treatment for Severe Cases
For patients experiencing difficulty breathing or low oxygen levels, oxygen therapy is essential to ensure that sufficient oxygen is delivered to vital organs. This can be provided through nasal prongs, masks, or more advanced methods, depending on the severity of the condition.
Antiviral medications such as Remdesivir may be prescribed to help reduce the replication of the virus in the body, potentially shortening the duration of illness and preventing further complications. This treatment is generally used for severe cases under medical supervision.
Steroids like dexamethasone are used to reduce inflammation in the body, especially in severe cases where inflammation is impacting lung function. They are typically used when the disease causes severe respiratory issues, such as pneumonia or ARDS (acute respiratory distress syndrome).
IV fluids are administered to patients who are severely dehydrated or unable to take fluids orally. This helps maintain hydration and supports normal body functions, especially in cases where patients experience gastrointestinal issues or significant fluid loss.
For patients with life-threatening symptoms, ICU support is necessary. Intensive care units provide continuous monitoring and advanced treatments, including mechanical ventilation for patients unable to breathe independently and other life-saving interventions.
Do Vaccines Still Work Against JN.1?
Vaccines authorised for emergency use, such as those developed by Pfizer-BioNTech, Moderna, and Covaxin, continue to provide protection against severe illness, hospitalisation, and death caused by the JN.1 variant. However, the effectiveness of these vaccinations in preventing infection is likely to be reduced due to the current variant's immune evasion properties.
While booster doses may enhance protection, particularly for high-risk individuals like the elderly and those with underlying health conditions, medical specialists recommend staying up to date with vaccinations and boosters to mitigate the impact of COVID-19.
Should People Start Wearing Masks Again?
Doctors recommend the use of masks for vulnerable populations such as elderly individuals, people with chronic illness, pregnant women, and those with compromised immunity, in public places.
For the general public, wearing masks remains a crucial preventive measure, especially in areas with high transmission rates or when in crowded or enclosed spaces. Masks help reduce the spread of respiratory droplets and protect both the wearer and others from potential exposure to the virus. Additionally, it can also reduce transmission from the infected individual even if symptoms are mild. Widespread mask use in certain settings can help prevent further spikes in cases.
In addition to masking, experts continue to stress the importance of good hygiene practices, such as frequent handwashing and using hand sanitizers. People are also advised to stay alert to symptoms like cough, fatigue, or fever and seek medical attention early if needed. Staying updated with local health advisories is crucial, as guidelines may evolve based on the spread of the variant.
Can JN.1 Lead to Complications?
While most cases of JN.1 infections are mild, there is a potential for complications, particularly in vulnerable populations. People with weakened immune systems, older adults, and those with underlying health conditions such as heart disease, diabetes, chronic respiratory issues, or cancer are more susceptible to complications such as:
In certain cases, individuals infected with JN.1 may experience co-infections with influenza or other respiratory viruses, which can worsen outcomes. Delayed diagnosis or self-treatment without medical supervision may also increase the risk of complications. Therefore, prompt medical attention and early intervention can help manage severe cases and reduce the chances of complications.
While JN.1 does not typically cause major complications in healthy individuals, it can still pose significant health risks for vulnerable groups. Staying up to date on vaccinations, seeking timely medical care, and following basic precautions can greatly reduce the chances of severe illness.
Is JN.1 a Cause for Panic in India?
JN.1 is known to be highly transmissible, which explains the recent rise in case numbers across certain states in India. However, high spread does not imply high danger, particularly when most cases do not lead to complications or require hospitalization. This makes it important to stay alert, but not alarmed.
Also, health authorities emphasise that the situation remains under control with the majority of cases being mild, which have not overwhelmed the healthcare system.
Subsequently, vaccination continues to play a key role in keeping JN.1 manageable. While breakthrough infections can occur, vaccines significantly reduce the risk of severe disease. Moreover, booster doses are especially important for older adults and those with underlying health conditions.
However, continued vigilance is necessary. Health experts recommend adhering to preventive measures, staying informed about the latest developments, and seeking medical advice if symptoms develop.
To summarize, while JN.1 has led to a modest increase in COVID-19 cases, it is not a cause for panic. Instead, it is a reminder to maintain basic preventive practices such as good hygiene, mask-wearing in high-risk settings, monitoring symptoms, and seeking timely care if unwell.
Prevention and Protective Measures to Follow for JN.1 Variant
The JN.1 variant may not be severe for most, but prevention remains key to controlling its spread, especially to protect vulnerable individuals. Practicing the following habits not only helps reduce your personal risk but also supports broader community health efforts:
Vaccination continues to provide protection against severe disease and hospitalization, even with newer variants like JN.1. Ensure you have completed the recommended COVID-19 vaccine doses, including booster shots if eligible.
Use a well-fitted mask in crowded, enclosed, or poorly ventilated spaces, especially if you are older, immunocompromised, or have chronic health conditions. Also wear mask in public transport, hospitals, and indoor public gatherings are settings where masking is especially recommended.
Wash hands regularly with soap and water for at least 20 seconds, or use alcohol-based hand sanitizers when soap and water are not available, particularly after touching shared surfaces or coughing/sneezing.
Maintain a Healthy Lifestyle
Support your immune system by eating a balanced diet, staying physically active, getting adequate sleep, and managing stress. Quit smoking and limit alcohol consumption to improve overall respiratory and immune health.
Prefer open or well-ventilated spaces whenever possible and avoid close contact with people showing symptoms like cough or fever.
Be vigilant for symptoms of COVID-19 and seek testing if symptoms develop. If you feel unwell, avoid social gatherings and consider getting tested. Self-isolate if you test positive, and follow medical advice.
Artemis Hospitals Offer Comprehensive Treatment for COVID-19 and other Respiratory Disorders by Top Pulmonologists in Gurgaon, India
Artemis Hospital’s department of pulmonology deals with the medical conditions affecting the lungs and the respiratory system. Department has the facility for the evaluation & management of the entire range of acute & chronic respiratory diseases such COVId-19, asthma and respiratory allergies, COPD, ILD, lung cancer, autoimmune disorders, sleep related disorders and chest wall disorders.
The Department is integrated with the Critical Care unit to provide comprehensive care to patients requiring life support. A highly qualified team of intensive care specialists is available 24X7. Procedures like ECMO & CRRT are undertaken. Apart from the expertise, the department is well equipped with the latest diagnostic & therapeutic technologies in the field of respiratory care. We have the capability for the evaluation & management of the entire range of acute & chronic respiratory diseases, such as:
Respiratory High Dependency Unit (RHDU)
Pulmonary Function Laboratory
Video Assisted Bronchoscopy
Sleep Service
Pulmonary Rehabilitation
Speciality Clinic
Artemis Hospitals’ Pulmonology & Critical Care Centre is equipped with
Endobronchial ultrasound system (EBUS)
Video Bronchoscopy Suite
Comprehensive Sleep Lab (PSG)
Integrated Intensive Care
Pulmonology Rehabilitation
PFT, DLCO
Article By Dr. Arun Chowdary Kotaru
Unit Head & Sr. Consultant - Pulmonology
Artemis Hospitals
Frequently Asked Questions
What are the symptoms of JN.1?
Common symptoms include sore throat, fatigue, cough, low-grade fever, body aches, and nasal congestion. Some people may also report gastrointestinal discomfort and brain fog.
Is JN.1 more dangerous than previous variants?
So far, JN.1 does not appear to cause more severe illness than previous variants. Most infections are mild, especially in vaccinated individuals. However, individuals with certain respiratory conditions are at an increased risk of complications.
Should I wear a mask to protect against JN.1?
Yes, especially in crowded indoor settings or around high-risk individuals. Masks help reduce the spread of airborne viruses, including JN.1.
Do existing COVID-19 vaccines protect against JN.1?
Yes, vaccines provide strong protection against severe illness and hospitalization. Also, booster doses are especially helpful for high-risk individuals and can protect against JN.1 variant.
Should I get a booster shot for JN.1?
If you're over 60, and your immunity is compromised, or have chronic illnesses, a booster is recommended. It can help enhance immunity against emerging variants.
How can I protect myself from JN.1?
Practice good hygiene, avoid crowded spaces, wear masks when needed, stay updated on vaccinations, and monitor your health regularly.
Is there a need to panic about JN.1?
No. While it's important to stay alert and follow precautions, JN.1 has not shown increased severity and is being closely monitored by health authorities.
How often should high-risk individuals get tested during this resurgence?
High-risk individuals should consider testing if they show any symptoms or have had known exposure to COVID-19. Routine testing is not needed unless advised by the pulmonologist.
Where can I get the best treatment for COVID-19 in Gurgaon?
Artemis Hospital’s department of pulmonology deals with the medical conditions affecting the lungs and the respiratory system. The hospital provides advance diagnostic evaluation & management of the entire range of acute & chronic respiratory diseases such COVId-19, COPD, ILD, autoimmune disorders, sleep related disorders and chest wall disorders, etc. To know more, get in touch with us.
How to differentiate between symptoms of flu and JN.1?
JN.1 and flu symptoms can overlap, but loss of taste/smell and shortness of breath are more COVID-specific. Testing is the most reliable way to distinguish between them.
Can someone get infected with JN.1 even after having COVID-19 before?
Yes. Prior infection provides some immunity, but it may wane over time, and JN.1 has mutations that can partially evade previous immunity.
How long does it take to recover from the JN.1 variant of COVID-19?
Most people recover within 5–7 days with rest and home care. Those with underlying conditions or older age may take longer and require closer monitoring.
